C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 121 filers reported holding C4 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $943,000 | -52.6% | 107,568 | -59.2% | 0.01% | -50.0% |
Q2 2022 | $1,990,000 | +1.5% | 263,930 | +333.4% | 0.01% | -9.1% |
Q4 2021 | $1,961,000 | -58.3% | 60,903 | -42.2% | 0.01% | -63.3% |
Q3 2021 | $4,705,000 | +29.2% | 105,314 | +9.4% | 0.03% | +20.0% |
Q2 2021 | $3,643,000 | – | 96,278 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,642,210 | $39,840,000 | 3.87% |
Paradigm Biocapital Advisors LP | 499,496 | $12,118,000 | 3.20% |
Cypress Point Wealth Management, LLC | 118,573 | $2,877,000 | 2.92% |
COMMODORE CAPITAL LP | 481,094 | $11,671,000 | 2.61% |
Nextech Invest Ltd. | 375,857 | $9,118,000 | 2.60% |
RTW INVESTMENTS, LP | 4,531,982 | $109,946,000 | 2.28% |
SPHERA FUNDS MANAGEMENT LTD. | 362,528 | $8,795,000 | 1.24% |
Perceptive Advisors | 2,082,723 | $50,526,000 | 1.01% |
CLOUGH CAPITAL PARTNERS L P | 356,181 | $8,641,000 | 0.66% |
HighVista Strategies LLC | 34,760 | $843,000 | 0.54% |